On The Rate and Extent of Drug Delivery to the Brain
Open Access
- 5 December 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 25 (8), 1737-1750
- https://doi.org/10.1007/s11095-007-9502-2
Abstract
To define and differentiate relevant aspects of blood–brain barrier transport and distribution in order to aid research methodology in brain drug delivery. Pharmacokinetic parameters relative to the rate and extent of brain drug delivery are described and illustrated with relevant data, with special emphasis on the unbound, pharmacologically active drug molecule. Drug delivery to the brain can be comprehensively described using three parameters: K p,uu (concentration ratio of unbound drug in brain to blood), CLin (permeability clearance into the brain), and V u,brain (intra-brain distribution). The permeability of the blood–brain barrier is less relevant to drug action within the CNS than the extent of drug delivery, as most drugs are administered on a continuous (repeated) basis. K p,uu can differ between CNS-active drugs by a factor of up to 150-fold. This range is much smaller than that for log BB ratios (K p), which can differ by up to at least 2,000-fold, or for BBB permeabilities, which span an even larger range (up to at least 20,000-fold difference). Methods that measure the three parameters K p,uu, CLin, and V u,brain can give clinically valuable estimates of brain drug delivery in early drug discovery programmes.This publication has 118 references indexed in Scilit:
- Norfloxacin Blood-Brain Barrier Transport in Rats Is Not Affected by Probenecid CoadministrationAntimicrobial Agents and Chemotherapy, 2006
- Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamicsAdvanced Drug Delivery Reviews, 2004
- Log(BB), PS products and in silico models of drug brain penetrationDrug Discovery Today, 2004
- Prediction of blood–brain barrier penetration: are we missing the point?Drug Discovery Today, 2004
- Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical SettingClinical Pharmacokinetics, 2002
- Blood‐brain barrier transport and brain distribution of morphine‐6‐glucuronide in relation to the antinociceptive effect in rats – pharmacokinetic/pharmacodynamic modellingBritish Journal of Pharmacology, 2001
- Development of anIn SituMouse Brain Perfusion Model and its Application tomdr1aP-Glycoprotein-Deficient MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- Intracerebral Dialysis and the Blood‐Brain BarrierJournal of Neurochemistry, 1995
- Microwave Fixation for the Determination of Cerebral Blood Volume in RatsJournal of Cerebral Blood Flow & Metabolism, 1993
- Postnatal development of bulk flow in the cerebrospinal fluid system of the albino rat: Clearance of carboxyl-[14C]inulin after intrathecal infusionBrain Research, 1973